Magnetic control of neuronal activity offers many obvious advantages over electric, optogenetic and chemogenetic manipulations. A recent series of highly visible papers reported the development of magnetic actuators (i.e., Magneto, MagR and αGFP−TRPV1/GFP−ferritin) that appeared to be effective in controlling neuronal firing 1-3 , yet their action mechanisms seem to conflict with the principles of physics 4 . We found that neurons expressing Magneto, MagR and αGFP−TRPV1/GFP−ferritin did not respond to magnetic stimuli with any membrane depolarization (let alone action potential firing), although these neurons frequently generated spontaneous action potentials. Because the previous study did not establish the precise temporal correlation between magnetic stimuli and action potentials in recorded neurons 1-3 , the reported magnetically-evoked action potentials are likely to represent mismatched spontaneous firings.
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Magneto-P2A-mCherry expressing cells (Fig 1b-c) . Together, these results suggest that unlike wild type TRPV4, the ferritin-conjugated variant of TRPV4, i.e., Magneto2.0, fails to form a functional ion channel and/or incorporate into the plasma membrane of 293T cells.
To test whether Magneto might evoke action potentials in neuronal cells, we first expressed mCherry-fused Magneto2.0, aka Magneto-Ts-mCherry, and Magneto-P2A-mCherry in CA1 neurons of cultured rat hippocampal slices using the established Sindbis viral expression system (Fig 1d; see 6, 7 for the methods). Two-photon images showed that Magneto-Ts-mCherry, although robustly expressed, seemed to have limited, if any, presence at the plasma membrane of CA1 neurons (Fig 1d insets) . In consistent, Western blots showed that in contrast to TPRV4 in TRPV4-P2A-ferritin-P2A-mCherry expressing CA1 cells, Magneto2.0 membrane surface expression was minimal despite its high intracellular expression in Magneto-P2A-mCherry expressing CA1 cells (Fig 1e-g) .
To verify the results, we expressed Magneto-P2A-mCherry and TRPV4-P2A-ferritin-P2A-mCherry in the mouse barrel cortex in vivo for 7-10-days using the established lentiviral expression system (Fig S3; see 6 for the methods). Again, in spite of high intracellular expressions, only TPRV4, but not Magneto2.0, showed efficient membrane surface expression in barrel cortical neurons (Fig S3) . These results are consistent with the fact that C-terminus of the Magneto2.0 primogenitor TRPV4, which is essential for surface trafficking and functional expression of TRPV4 5 , is deleted in Magneto2.0 2 . We then made simultaneous whole-cell recordings from pairs of control non-expressing and Magneto-P2A-mCherry expressing CA1 cells. Patch-clamp recordings showed that application of up to 64.5 mT static magnetic field induced neither depolarization nor action potential firing in control and Magneto-P2A-mCherry expressing CA1 cells (Fig 1h-i) . Similarly, the magnetic stimuli failed to induce depolarization and action potential discharge in Magneto-P2A-mCherry expressing CA1 cells when the expression was made with lentivirus ( Fig S4) . These results indicate that the magnetic stimuli do not induce action potential in Magneto expressing CA1 neurons in cultured slices.
To further examine Magneto, we made in vivo Sindbis viral expression of Magneto-P2A-mCherry in layer 2/3 pyramidal and stellate neurons in the mouse medial entorhinal cortex (MEC) or layer 5 pyramidal neurons in the mouse barrel cortex for ~18 hrs, and then acutely prepared entorhinal or barrel cortical slices (Figs S5a and S6a). Simultaneous recordings showed that the 64.5 mT static magnetic field did not induce any depolarization or action potential firing in control and Magneto-P2A-mCherry expressing neurons (Figs S4 and S6) . We repeated the experiments using the same 3/8" permanent block magnet employed in the previous study 2 (Fig   S7a) . Positioning the magnet 5.00 mm away from recorded neurons, which yielded a 78.8 mT static magnetic field (Fig S1) , induced neither depolarization nor action potential firing in control and Magneto-P2A-mCherry expressing entorhinal neurons (Fig S7b-c) . In these experiments, we noted that control and Magneto-P2A-mCherry expressing entorhinal neurons frequently displayed spontaneous synaptic events, and at times, the spontaneous events reached the threshold and triggered bursts of action potentials (Figs S5b, S5d and S7b), suggest a potential cause for the reported magnetic effects 2 .
We then recorded hippocampal neurons after ~3-5-week in vivo AAV viral expression of DIO-Magneto and GFP-Cre (Fig S8a) , using the same brain slice tissues prepared and published in Wheeler et al. 2 . The 78.8 mT static magnetic field induced neither depolarization nor action potential discharge in control or Magneto expressing dentate gyrus neurons (Fig S8b-c) . Finally, we made in vivo AAV viral expression of DIO-Magneto and GFP-Cre in layer 2/3 pyramidal and stellate neurons of mouse MEC for ~3-5 weeks, and then recorded activity of entorhinal neurons in acutely prepared entorhinal cortical slices (Fig 1j) . Once again, simultaneous recordings showed that application of up to 64.5 mT static magnetic field did not induce any depolarization or action potential firing in control and DIO-Magneto/GFP-Cre expressing entorhinal neurons (Fig 1k-l) . Importantly, we observed abundant spontaneous activities that from time to time, reached the firing threshold and elicited action potentials in these experiments (Figs 1k, 1m , S8b and S8d). Collectively, our results consistently support the idea that Magneto does not function as an effective magnetic actuator and spontaneous action potentials can confound the interpretation of Magneto expressing neurons subjected to magnetic stimuli.
The above experiments raised the concern about the other two recently reported magnetic actuators, MagR and αGFP−TRPV1/GFP−ferritin, given no time correlation between magnetic stimuli and action potentials in MagR and αGFP−TRPV1/GFP−ferritin expressing neurons reported in the two other studies 1, 3 . To test whether MagR may serve as a magnetic actuator, we made Sindbis viral expression of MagR-P2A-GFP in CA1 neurons of 5 cultured rat hippocampal slices (Fig 2a) . After 18-hour expression, we made simultaneous whole-cell recordings from pairs of control non-expressing and MagR-P2A-GFP expressing CA1 cells. Application of up to 64.5 mT static magnetic field induced neither depolarization nor action potential firing in control and MagR-P2A-GFP expressing CA1 cells (Fig 2b-c) . These results are indicative of no magnetic effect on MagR expressing CA1 neurons, and the previously reported MagR-mediated action potentials to be confounding spontaneous firing (cf. 8 ).
We next examined whether αGFP−TRPV1/GFP−ferritin may serve as a magnetic actuator. In this experiment, we made Sindbis viral expression of αGFP−TRPV1-P2A-GFP−ferritinin hypothalamic neurons in intact mouse brains for 18 hours, and then made simultaneous whole-cell recordings from pairs of control non-expressing and αGFP−TRPV1/GFP−ferritin expressing hypothalamic neurons in acutely prepared slices (Fig 2d) . Following the previous report 3 , we delivered a K&J N52 neodymium 1/16" cylinder magnet to the position 500 μm away from recorded cells, which generated a 108.0-mT magnetic field (Fig S1) . Application of up to 108.0 mT static magnetic induced neither depolarization nor action potential discharge in control and αGFP−TRPV1/GFP−ferritin expressing hypothalamic neurons (Fig 2e-f) . Both control and αGFP−TRPV1/GFP−ferritin expressing hypothalamic neurons exhibited frequent spontaneous synaptic potentials, and at times, depolarizing spontaneous potentials reached the threshold to trigger a burst of action potentials (Figs 2e and 2g ). These results are suggestive of no magnetic effect on αGFP−TRPV1/GFP−ferritin expressing hypothalamic neurons and the previously reported αGFP−TRPV1/GFP−ferritin-mediated responses to be false positive magnetic effects caused by spontaneous activity.
DISCUSSION
In summary, we systematically investigated whether Magneto2.0 might function as a magnetic actuator with multiple approaches (i.e., transfection, Sindibis, lentivirus, and AAV viral expression in vitro and/or in vivo), multiple cell types (i.e., 293T cells, hippocampal CA1 neurons, dentate gyrus neurons, cortical L5 pyramidal neurons, entorhinal layer 2/3 stellate and pyramidal neurons), and multiple animal species (i.e., rats and mice).
Our results, together with two accompanied studies that used additional approaches (e.g. viral expression), cell 6 types (e.g., cerebral Purkinje neurons and barrel cortical layer 2/3 neurons), and manipulation/recording SFV methods (e.g., electric magnetic stimuli and in vivo recordings) 9, 10 , consistently support the notion that Magneto2.0 does not serve as a magnetic actuator. Our experiments raise serious concerns of about the experimental design and execution of Wheeler et al. study. For example, deleting C-terminus of the Magneto2.0 primogenitor TRPV4 2 , that is essential for surface trafficking of Magneto2.0 5 , is poorly conceived. Moreover, whether the ferritin subunit-fused TRPV4s may multiplex together to form functional ferritins remains to be tested.
Notably, Wheeler et al. used the recorded action potentials as the primary evidence to argue that Magneto2.0 serves as a magnetic actuator (and its surface expression) 2 , yet these electrophysiology recordings were poorly controlled and confounded by spontaneous action potentials. Thus, the rigorous electrophysiology experiment that is essential for validating Magneto as a magnetic actuator remains missing (also see 11 with data suggestive of the endoplasmic reticulum as the source of minimal intracellular Ca 2+ elevation). Indeed, with the location of stimulating magnets continuously monitored, multiple independent electrophysiological experiments in this study (some using the exact same magnetic stimulations and/or tissues prepared for Wheeler et al.), together with those in the two accompanied studies 9,10 , consistently demonstrated that Magneto did not respond to magnetic stimuli with any membrane depolarization (let alone action potential firing). We also show here that MagR and αGFP−TRPV1/GFP−ferritin do not produce any detectable magnetically-elicited membrane depolarization.
Together, these results support the theoretical conclusion that Magneto, MagR and αGFP−TRPV1/GFP−ferritin are incapable of controlling neuronal activity by producing magnetically-evoked action potentials. We hope that our comprehensive testing of Magneto establishes a sample set of criteria to aid continuing tool-engineering efforts, including building of a magnetogenetic toolbox. The criteria include: first, surface expression validation; second, functional validation; and third, electrophysiological validation. Obviously, beyond the proof-of-principle, the applicability of novel tools is best ensured by using them to answer fundamental biology questions in a definitive manner, as was typical of previous developments in patch-clamp and imaging technology. 
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METHODS

Animal preparation
Male and female Sprague Dawley rats and C57BL/6 mice were used to prepare cultured slices and acute slices used in this study. Animals were maintained in the animal facility at the University of Virginia and family or pair housed in the temperature-controlled animal room with 12-h/12-h light/dark cycle. Food and water were available ad libitum. All procedures for animal surgery and maintenance were performed following protocols approved by the Animal Care & Use Committee of the University of Virginia and in accordance with US National Institutes of Health guidelines.
Cultured slice preparation
Cultured slices were prepared from postnatal 6−7 day old rats or mice (P6−7) as reported in our previous studies 6, 7 . In brief, the hippocampi were dissected out in ice-cold HEPES-buffered Hanks' solution (pH 7.35) under sterile conditions, sectioned into 400-µm slices on a tissue chopper, and explanted onto a Millicell-CM membrane (0.4-µm pore size; Millipore). The membranes were then placed in 750 µl of MEM culture medium, contained (in mM): HEPES 30, heat-inactivated horse serum 20%, glutamine 1.4, D-glucose 16.25, NaHCO3 5, CaCl2 1, MgSO4 2, insulin 1 mg/ml, ascorbic acid 0.012% at pH 7.28 and osmolarity 320. Cultured slices were maintained at 35°C, in a humidified incubator (ambient air enriched with 5% CO2).
Constructs of recombinant proteins and expression
All constructs, including TRPV4-P2A-ferritin-P2A-mCherry, Magneto-P2A-mCherry and Magneto-Ts-mCherry were generously supplied by Drs Chris Deppmann and Ali Güler. Magneto-P2A-mCherry and Magneto-Ts-mCherry were subcloned into Sindbis and lenitiviral vectors. AAV viral solutions of the Cre-dependent Magneto2.0 AAV virus, aka AAV1-CMV::DIO-Magneto, and AAV9-Camk2a::EGFP-Cre were also supplied by Drs Chris Deppmann and Ali Güler. A P2A sequence was used to link clMagR 12 and GFP, and anti-GFP−TRPV1 and GFP−ferritin 13 to create clMagR-P2A-GFP and αGFP−TRPV1-P2A-GFP−ferritin, which were then subcloned into Sindbis viral vector. Construct expression followed our previous studies 14, 15 . For expression in cultured 293T cells, Magneto-P2A-mCherry and TRPV4-P2A-ferritin-P2A-mCherry were transfected using the calcium 9 phosphate transfection method. For expression in cultured slices, CA1 pyramidal neurons in hippocampal cultured slices were infected after 8−18 days in vitro with lentivirus or Sindbis virus, and then incubated on culture media and 5% CO2 before experiments. For expression in intact brains, P18−28 mice were initially anesthetized by an intraperitoneal injection of ketamine and xylazine (10 and 2 mg/kg, respectively). Animals were then placed in a stereotaxic frame and one or multiple small (~1×1 mm) holes were opened above the cortex. A glass pipette was used to make pressure injections of ~100 nl Sindbis or lentiviral solution, or 200 nl equivolume mixture of AAV viral solutions of AAV1-CMV::DIO-Magneto and AAV9-Camk2a::EGFP-Cre into the barrel cortex, hippocampus and/or MEC according to their stereotaxic coordinates. After injection, animals were allowed to recover from the anesthesia and returned to their cages. Experiments were typically performed within 18±2 hours after Sindbis viral infection, 7−10 days after lentiviral infection and 3−5 weeks after AAV viral infection.
Biochemical analysis
Hippocampal extracts were prepared by homogenizing hippocampal CA1 regions isolated from cultured slices, while cortical extracts were prepared by homogenizing mCherry expressing barrel cortical areas isolated from acute cortical slices. Membranes were blotted with anti-FLAG antibody (1:5,000 for in vitro expression, 1:2,000 for in vivo expression; Fisher Scientific, Hampton, NH; Cat# MA1-91878, RRID:AB_1957945), stripped and reblotted twice with anti-GluA1 (1:1,000 for in vitro expression; 1:1,000 for in vivo expression; EMD Millipore, Burlington, MA; Cat# AB1504, RRID:AB_2113602) or anti-GluA2 antibody (1:6,000 for in vitro expression; 1:6,000 for in vivo expression; EMD Millipore; Cat# AB1768, RRID:AB_2313802). Western blots were quantified by chemiluminescence and densitometric scanning of the films under linear exposure conditions. Two-photon imaging and electrophysiology were simultaneously performed using a custom-built microscope operated by a custom-written IGOR Pro 6 program (WaveMetrics, Lake Oswego, OR) 6, 16 . Neighboring expressing and non-expressing CA1 or dentate gyrus neuron pairs were broken in simultaneously to load green indicator Alexa 488 (20 μM). Images were taken ~15−30 minutes after loading of the indicator. Alexa 488 and mCherry were excited by a femtosecond Ti:Sapphire laser (Chameleon Ultra; Coherent, Santa Clara, CA) at a wavelength of 880 nm.
Electrophysiology and two-photon imaging
Agonist application and magnetic stimulation
TRPV4 agonist, GSK1016790A (EMD Millipore, Billerica, MA), was puff applied with a brief (1 sec) air pressure by a glass pipette mounted on a Luigs-Neumann JUNIOR COMPACT manipulator (Luigs-Neumann GmbH, Ratingen, Germany) and positioned ~150 µm away from the recorded 293T cells. TRPV4-specific antagonist GSK205 (EMD Millipore), was bath applied. Magnetic stimuli were made using axially magnetized magnets, including a 3/8" cylinder magnet used in the previous study 2 and N42 1/16" x 1/4" block neodymium magnets purchased from K&J Magnetics. The magnetic intensity-distance relationships of these magnets were calculated with an HT20 Gauss Tesla meter (Shanghai Hengtong Cidian Technology Co., Ltd., Shanghai, China) (Fig S1) .
A Luigs-Neumann JUNIOR COMPACT manipulator was used to mount and rapidly position the magnets to 1.00 mm (for N42 block magnets), 0.50 mm (for N52 cylinder magnets) or 5.00 mm (for the 3/8" cylinder magnet) away from recorded cells to create a static magnetic field >50 mT or >100 mT. After stimulation, the magnets were rapidly withdrawn by 12−15 mm to eliminate magnetic stimuli. To determine the precise timing of applied magnetic field, we used an LED illuminator and a photodetector (Thorlabs Inc, Newton, NJ) to monitor the exact position of magnets mounted on a Luigs-Neumann JUNIOR COMPACT manipulator.
Statistical analysis
Statistical results were reported as mean±s.e.m. Animals or cells were randomly assigned into control or experimental groups and investigators were blinded to experiment treatments. Given the negative correlation between the variation and square root of sample number, n, the group sample size was typically set to be ~10−25 to optimize the efficiency and power of statistical tests. Statistical significances of the means (p<0.05; two sides) were determined using Wilcoxon non-parametric tests for paired samples. The data that support the findings of this study are available from the corresponding authors upon request. 
